/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
TEXXR

Chronicles

The story behind the story

days · browse · Enter similar · o open

Anagenex, which combines AI and large-scale proprietary datasets for drug discovery, has raised a $30M Series A led by Catalio Capital Management

Arundhati Parmar / MedCity News :

MedCity News Arundhati Parmar

Discussion

  • @nanli Nan Li on x
    Congrats @ntilmans and Anagenex team on the milestone today!! Incredible platform layering computational chemistry on top of intentional, proprietary, and large scale DEL assays/datasets. https://twitter.com/...
  • @freelancestudio @freelancestudio on x
    Congratulations to @ntilmans and the @anagenex team on their Series A funding! Building a brand identity for a biotech company focused on drug discovery wasn't an easy task. The brand rollout will be staged as the team is small, but very excited to share over the next few months!…
  • @anagenex @anagenex on x
    Thrilled to announce our Series A financing led by @CatalioCapital joined by @Lux_Capital, @khoslaventures, @obviousvc, @airstreet, @MenloVentures and many others. Thank you for the support and here's to finding more medicines! https://www.businesswire.com/ ...